Epigenetic field defects in progression to cancer.

Abstract:

:A field defect is a field of pre-malignant tissue in which a new cancer is likely to arise. Field defects often appear to be histologically normal under the microscope. Recent research indicates that cells within a field defect characteristically have an increased frequency of epigenetic alterations and these may be fundamentally important as underlying factors in progression to cancer. However, understanding of epigenetic field defects is at an early stage, and the work of Katsurano et al published this year, is a key contribution to this field. One question examined by Katsurano et al was how early could the formation of an epigenetic field defect be detected in a mouse colitis model of tumorigenesis. They highlighted a number of measurable epigenetic alterations, detected very early in normal appearing tissue undergoing histologically invisible tumorigenesis. They also documented the increasing presence of the epigenetic alterations at successive times during progression to cancer. In this commentary, we offer a perspective on the changes they observed within a broader sequence of epigenetic events that occur in progression to cancer. In particular, we highlight the likely central role of epigenetic deficiencies in DNA repair gene expression that arise during progression to cancer.

authors

Bernstein C,Nfonsam V,Prasad AR,Bernstein H

doi

10.4251/wjgo.v5.i3.43

subject

Has Abstract

pub_date

2013-03-15 00:00:00

pages

43-9

issue

3

issn

1948-5204

journal_volume

5

pub_type

杂志文章
  • Markers of bile duct tumors.

    abstract::Biliary tract carcinomas are relatively rare, representing less than 1% of cancers. However, their incidence has increased in Japan and in industrialized countries like the USA. Biliary tract tumors have a poor prognosis and a high mortality rate because they are usually detected late in the course of the disease; the...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v3.i4.49

    authors: Malaguarnera G,Giordano M,Paladina I,Rando A,Uccello M,Basile F,Biondi A,Carnazzo S,Alessandria I,Mazzarino C

    更新日期:2011-04-15 00:00:00

  • Multimodality treatment of recurrent pancreatic cancer: Mith or reality?

    abstract::Pancreatic adenocarcinoma is the fourth cause of cancer-related death in the United States. Surgery is the only potentially curative treatment, but most patients present at diagnosis with unresectable or metastatic disease. Moreover, even with an R0 resection, the majority of patients will die of disease recurrence. M...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v7.i12.375

    authors: Sperti C,Moletta L,Merigliano S

    更新日期:2015-12-15 00:00:00

  • Current strategies for malignant pedunculated colorectal polyps.

    abstract::Despite significant advances in imaging techniques, the incidence of colorectal cancer has been increasing in recent years, with many cases still being diagnosed in advanced stages. Early detection and accurate staging remain the main factors that lead to a decrease in the cost and invasiveness of the curative techniq...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v10.i12.465

    authors: Ciocalteu A,Gheonea DI,Saftoiu A,Streba L,Dragoescu NA,Tenea-Cojan TS

    更新日期:2018-12-15 00:00:00

  • LncRNA C9orf139 can regulate the growth of pancreatic cancer by mediating the miR-663a/Sox12 axis.

    abstract:BACKGROUND:Recent studies have proved the important role of many oncogenic long non-coding RNAs (lncRNAs) in the progression of pancreatic cancer, but little is known about the mechanisms of tumor suppression in pancreatic cancer. AIM:To evaluate the function of tumor suppressor lncRNA C9orf139 in pancreatic cancer pr...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v12.i11.1272

    authors: Ge JN,Yan D,Ge CL,Wei MJ

    更新日期:2020-11-15 00:00:00

  • Targeted therapy or immunotherapy? Optimal treatment in hepatocellular carcinoma.

    abstract::Hepatocellular carcinoma (HCC) is the fifth leading cause of cancer mortality in the United States and the second leading cause of cancer mortality worldwide. Sorafenib is the only food and drug administration (FDA) approved as first line systemic treatment in HCC. Regorafenib and nivolumab are the only FDA approved s...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v10.i5.108

    authors: Contratto M,Wu J

    更新日期:2018-05-15 00:00:00

  • Potential of casein kinase I in digestive cancer screening.

    abstract::Casein kinase I is a group of ubiquitous Serine/Threonine kinases that have been implicated in both normal cellular functions and several pathological conditions including Alzheimer's disease and cancer. Recent findings in colon and pancreatic cancer have brought tremendous attention to these molecules as potential th...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v1.i1.26

    authors: Modak C,Chai J

    更新日期:2009-10-15 00:00:00

  • Polyethylene glycol microspheres loaded with irinotecan for arterially directed embolic therapy of metastatic liver cancer.

    abstract:AIM:To study tumor response, and tolerability of arterially directed embolic therapy (ADET) with polyethylene glycol embolics loaded with irinotecan for the treatment of colorectal cancer liver metastases (CRC-LM). Secondary objectives were to monitor quality of life, time to progression and survival of patients. METH...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v9.i9.379

    authors: Fiorentini G,Carandina R,Sarti D,Nardella M,Zoras O,Guadagni S,Inchingolo R,Nestola M,Felicioli A,Barnes Navarro D,Munoz Gomez F,Aliberti C

    更新日期:2017-09-15 00:00:00

  • Endoscopic electronic record: A new approach for improving management of colorectal cancer prevention.

    abstract::Digestive endoscopy is currently the main diagnostic procedure for investigation of the digestive tract when a digestive disease is suspected. The use of computers and electronic medical records for the management of endoscopic data are an important key to improving endoscopy unit efficiency and productivity. This tec...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v4.i4.76

    authors: Maserat E,Safdari R,Maserat E,Zali MR

    更新日期:2012-04-15 00:00:00

  • Minimally invasive surgical approach to pancreatic malignancies.

    abstract::Pancreatic surgery for malignancy is recognized as challenging for the surgeons and risky for the patients due to consistent perioperative morbidity and mortality. Furthermore, the oncological long-term results are largely disappointing, even for those patients who experience an uneventfully hospital stay. Nevertheles...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v7.i12.411

    authors: Bencini L,Annecchiarico M,Farsi M,Bartolini I,Mirasolo V,Guerra F,Coratti A

    更新日期:2015-12-15 00:00:00

  • From traditional serrated adenoma to tubulovillous adenoma and beyond.

    abstract::It is well established that colorectal cancer develops from a series of precursor epithelial polyps, including tubular adenomas, villous/tubulovillous adenomas (VA/TVA), sessile serrated adenomas (SSA) and traditional serrated adenomas (TSA). Of these, TSAs are least common and account for only 5% of all serrated poly...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v8.i12.805

    authors: Kalimuthu SN,Chelliah A,Chetty R

    更新日期:2016-12-15 00:00:00

  • Colorectal cancer metastatic to the breast: A case report.

    abstract:BACKGROUND:Breast metastases from colorectal cancer (CRC) are very uncommon. There is no unanimous consensus regarding the best treatment for this rare condition, and management is, especially in elderly patients, limited to diagnosis and palliative care. Capecitabine, an oral fluoropyrimidine derivative, might be help...

    journal_title:World journal of gastrointestinal oncology

    pub_type:

    doi:10.4251/wjgo.v12.i9.1073

    authors: Taccogna S,Gozzi E,Rossi L,Caruso D,Conte D,Trenta P,Leoni V,Tomao S,Raimondi L,Angelini F

    更新日期:2020-09-15 00:00:00

  • Pneumo-CT assessing response to neoadjuvant therapy in esophageal cancer: Imaging-pathological correlation.

    abstract::Pneumo-computed tomography (PnCT) is a technique primarily developed and used to study stenotic lesions of the esophagus, gastroesophageal junction and stomach for pre-surgical planning. It helps to define both upper and lower borders of neoplasms located in the aforementioned areas. It achieves maximum lumen distensi...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v5.i12.222

    authors: Ulla M,Gentile E,Yeyati EL,Diez ML,Cavadas D,Garcia-Monaco RD,Ros PR

    更新日期:2013-12-15 00:00:00

  • Efficacy and safety of intraoperative radiotherapy in rectal cancer: A systematic review and meta-analysis.

    abstract:BACKGROUND:In recent years, intraoperative radiotherapy (IORT) has been increasingly used for the treatment of rectal cancer. However, the efficacy and safety of IORT for the treatment of rectal cancer are still controversial. AIM:To evaluate the value of IORT for patients with rectal cancer. METHODS:We searched PubM...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v13.i1.69

    authors: Liu B,Ge L,Wang J,Chen YQ,Ma SX,Ma PL,Zhang YQ,Yang KH,Cai H

    更新日期:2021-01-15 00:00:00

  • Low rectal cancer: Sphincter preserving techniques-selection of patients, techniques and outcomes.

    abstract::Low rectal cancer is traditionally treated by abdominoperineal resection. In recent years, several new techniques for the treatment of very low rectal cancer patients aiming to preserve the gastrointestinal continuity and to improve both the oncological as well as the functional outcomes, have been emerged. Literature...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v7.i7.55

    authors: Dimitriou N,Michail O,Moris D,Griniatsos J

    更新日期:2015-07-15 00:00:00

  • Optimizing outcomes for patients with gastric cancer peritoneal carcinomatosis.

    abstract::Peritoneal carcinomatosis (PC) from gastric cancer has traditionally been considered a terminal progression of the disease and is associated with poor survival outcomes. Positive peritoneal cytology similarly worsens the survival of patients with gastric cancer and treatment options for these patients have been limite...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 社论

    doi:10.4251/wjgo.v10.i10.282

    authors: Leiting JL,Grotz TE

    更新日期:2018-10-15 00:00:00

  • Targeted agents for second-line treatment of advanced hepatocellular carcinoma.

    abstract::Over the past ten years, sorafenib, a multikinase inhibitor, has been the standard of care for patients with unresectable hepatocellular carcinoma (HCC) and well-preserved liver function. Recently, lenvatinib, a different multikinase inhibitor, was shown to be non-inferior to sorafenib, in terms of survival, while all...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v11.i10.788

    authors: Personeni N,Pressiani T,Bozzarelli S,Rimassa L

    更新日期:2019-10-15 00:00:00

  • Epigenetic reduction of DNA repair in progression to gastrointestinal cancer.

    abstract::Deficiencies in DNA repair due to inherited germ-line mutations in DNA repair genes cause increased risk of gastrointestinal (GI) cancer. In sporadic GI cancers, mutations in DNA repair genes are relatively rare. However, epigenetic alterations that reduce expression of DNA repair genes are frequent in sporadic GI can...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v7.i5.30

    authors: Bernstein C,Bernstein H

    更新日期:2015-05-15 00:00:00

  • Carcinogenesis and chemoprevention of biliary tract cancer in pancreaticobiliary maljunction.

    abstract::Pancreaticobiliary maljunction (PBM) is a high risk factor for biliary tract cancer. In PBM, since the pancreatic duct and bile duct converge outside the duodenal wall beyond the influence of the sphincter of Oddi, pancreatic juice and bile are constantly mixed, producing a variety of harmful substances. Because of th...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v2.i3.130

    authors: Tsuchida A,Itoi T

    更新日期:2010-03-15 00:00:00

  • Utilizing gastric cancer organoids to assess tumor biology and personalize medicine.

    abstract::While the incidence and mortality of gastric cancer (GC) have declined due to public health programs, it remains the third deadliest cancer worldwide. For patients with early disease, innovative endoscopic and complex surgical techniques have improved survival. However, for patients with advanced disease, there are li...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v11.i7.509

    authors: Lin M,Gao M,Cavnar MJ,Kim J

    更新日期:2019-07-15 00:00:00

  • Clinical significance of SQSTM1/P62 and nuclear factor-κB expression in pancreatic carcinoma.

    abstract:BACKGROUND:Overexpression of SQSTM1 (sequestosome 1, P62) and nuclear factor-κB (NF-κB) plays an important role in the invasion and metastasis of a variety of malignant tumors. AIM:To explore the expression of P62 and NF-κB in pancreatic cancer and their relationship with clinicopathological features. METHODS:The exp...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v12.i7.719

    authors: Zhang ZY,Guo S,Zhao R,Ji ZP,Zhuang ZN

    更新日期:2020-07-15 00:00:00

  • Fibrin sealant for esophageal anastomosis: A phase II study.

    abstract:BACKGROUND:Esophagectomy is a pivotal curative modality for localized esophageal or esophagogastric junction cancer (EC or EJC). Postoperative anastomotic leakage (AL) remains problematic. The use of fibrin sealant (FS) may improve the strength of esophageal anastomosis and reduce the incidence of AL. AIM:To assess th...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 临床试验

    doi:10.4251/wjgo.v12.i6.651

    authors: Lin YB,Fu JH,Huang Y,Hu YH,Luo KJ,Wang KX,Bella AÉ,Situ DR,Chen JY,Lin T,D'Journo XB,Novoa NM,Brunelli A,Fernando HC,Cerfolio RJ,Ismail M,Yang H,AME Thoracic Surgery Collaborative Group.

    更新日期:2020-06-15 00:00:00

  • Comparison of survival between adolescent and young adult vs older patients with hepatocellular carcinoma.

    abstract:BACKGROUND:Due to the special clinical features and biologic characteristics of adolescent and young adult (AYA) cancers, AYA cancers are different from cancers in children and elderly individuals. However, there are few reports on AYA hepatocellular carcinoma (HCC). AIM:To investigate the overall survival (OS) of AYA...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v12.i12.1394

    authors: Ren J,Tong YM,Cui RX,Wang Z,Li QL,Liu W,Qu K,Zhang JY,Liu C,Wan Y

    更新日期:2020-12-15 00:00:00

  • Paraneoplastic leukemoid reaction in pancreatic cancer: A case report.

    abstract::Paraneoplastic leukemoid reaction is a rare syndrome defined by a leukocyte count exceeding 50 Giga/Liter (G/L), mostly described with progressive lung or renal carcinoma. We report a case of a 68-year-old man with recurrent pancreatic carcinoma presenting a leukemoid reaction with a white blood cell count of 63.87 G/...

    journal_title:World journal of gastrointestinal oncology

    pub_type:

    doi:10.4251/wjgo.v7.i10.259

    authors: Dos Santos M,Bouhier K,Dao MT

    更新日期:2015-10-15 00:00:00

  • Pathology handling of pancreatoduodenectomy specimens: Approaches and controversies.

    abstract::Pancreatic cancer, with a 5% 5-year survival rate, is the fourth leading cause of cancer death in Western countries. Unfortunately, only 20% of all patients benefit from surgical treatment. The need to prolong survival has prompted pathologists to develop improved protocols to evaluate pancreatic specimens and their s...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v6.i9.351

    authors: Gómez-Mateo Mdel C,Sabater-Ortí L,Ferrández-Izquierdo A

    更新日期:2014-09-15 00:00:00

  • Parenchyma-sparing pancreatectomies for benign or border-line tumors of the pancreas.

    abstract::Standard pancreatic resections, such as pancreaticoduodenectomy, distal pancreatectomy, or total pancreatectomy, result in an important loss of normal pancreatic parenchyma and may cause impairment of exocrine and endocrine function. Whilst these procedures are mandatory for malignant tumors, they seem to be too exten...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v2.i6.272

    authors: Sperti C,Beltrame V,Milanetto AC,Moro M,Pedrazzoli S

    更新日期:2010-06-15 00:00:00

  • Isolated pancreatic metastasis of hepatocellular carcinoma after curative resection.

    abstract::Hepatocellular carcinoma (HCC) is a highly malignant tumor and extrahepatic metastasis is not rare. The most common organ of HCC metastasis is lung, followed by bone and adrenal gland. To the best of our knowledge, isolated pancreatic metastasis of HCC that developed after curative resection has not been described pre...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v2.i4.209

    authors: Woo SM,Park JW,Han SS,Choi JI,Lee WJ,Park SJ,Hong EK,Kim CM

    更新日期:2010-04-15 00:00:00

  • Pathological aspects of so called "hilar cholangiocarcinoma".

    abstract::Cholangiocarcinoma (CC) arising from the large intrahepatic bile ducts and extrahepatic hilar bile ducts share clinicopathological features and have been called hilar and perihilar CC as a group. However, "hilar and perihilar CC" are also used to refer exclusively to the intrahepatic hilar type CC or, more commonly, t...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v5.i7.159

    authors: Castellano-Megías VM,Ibarrola-de Andrés C,Colina-Ruizdelgado F

    更新日期:2013-07-15 00:00:00

  • Extrapancreatic solid pseudopapillary neoplasm followed by multiple metastases: Case report.

    abstract::Solid pseudopapillary neoplasm (SPN), also known as Gruber-Frantz tumor, is a rare form of neoplasm that almost exclusively occurs in the pancreas and in young females. While the potential of malignancy is low for SPN, these tumors can mimic other diseases and require a meticulous investigation and a standard treatmen...

    journal_title:World journal of gastrointestinal oncology

    pub_type:

    doi:10.4251/wjgo.v9.i12.497

    authors: Wu H,Huang YF,Liu XH,Xu MH

    更新日期:2017-12-15 00:00:00

  • Circulating cytokines and outcome in metastatic colorectal cancer patients treated with regorafenib.

    abstract:BACKGROUND:Regorafenib is an oral small-molecule multikinase inhibitor approved in third or later line of treatment for patients with metastatic colorectal cancer (mCRC). Regorafenib has shown significant benefits in overall survival and progression free survival in two phase III trials compared to placebo in patients ...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章

    doi:10.4251/wjgo.v12.i3.301

    authors: Ricci V,Granetto C,Falletta A,Paccagnella M,Abbona A,Fea E,Fabozzi T,Lo Nigro C,Merlano MC

    更新日期:2020-03-15 00:00:00

  • Emerging molecular targets and therapy for cholangiocarcinoma.

    abstract::Cholangiocarcinoma (CCA) is a rare cancer arising from the biliary tree with a poor prognosis and limited therapeutic options. Recent large scale molecular characterisation studies have identified recurrent genetic alterations in CCA which may be amenable to therapeutic targeting. In this review we explore the genomic...

    journal_title:World journal of gastrointestinal oncology

    pub_type: 杂志文章,评审

    doi:10.4251/wjgo.v9.i7.268

    authors: Kayhanian H,Smyth EC,Braconi C

    更新日期:2017-07-15 00:00:00